GlassScriptPhysician profile
Snigdha Ancha
NPI 1851679351
$13,110.76
in general payments reported to CMS, 2019-2025
29 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $895 · 2021: $2,856 · 2022: $1,459 · 2023: $578 · 2024: $3,159 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,107 · Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,107.25 |
| Food and Beverage | $2,231.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,175.81 | 2019-2025 | Watchman Flx, General - Structural Heart, Watchman |
| Pacira Pharmaceuticals Incorporated | $2,129.14 | 2021-2025 | Iovera |
| Spinal Simplicity, LLC | $1,260.18 | 2025 | Ha Minuteman G3-R, Patriot Si, Liberty Si |
| Medtronic, INC. | $1,005.43 | 2021-2025 | Inceptiv |
| Relievant Medsystems, INC. | $851.28 | 2019-2023 | Intracept |
| Medtronic USA, INC. | $794.85 | 2019-2020 | |
| Aurora Spine, INC. | $624.20 | 2022 | |
| Spr Therapeutics, INC | $290.20 | 2021-2023 | Sprint Pns System |
| Zyla Life Sciences, INC. | $124.02 | 2019 | |
| Nevro Corp. | $100.71 | 2019-2024 | Senza |
| Allergan, INC. | $95.53 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $77.85 | 2020 | |
| Arbor Pharmaceuticals, INC. | $60.03 | 2019-2020 | |
| Avanos Medical | $57.38 | 2019-2021 | |
| Pfizer INC. | $55.07 | 2019-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $50.34 | 2019 | |
| Sanofi-Aventis U.S. LLC | $47.64 | 2019-2020 | |
| Abbott Laboratories | $40.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.23 | 2019 | |
| Nalu Medical, INC. | $37.57 | 2022 | |
| Biodelivery Sciences International, INC. | $33.26 | 2019 | |
| Stimwave Technologies Incorporated | $32.54 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $25.97 | 2019-2020 | |
| Abbvie INC. | $24.32 | 2022 | |
| Globus Medical, INC. | $20.92 | 2025 | Senza |
| Bioventus LLC | $17.23 | 2019 | |
| Shionogi INC | $16.39 | 2019 | |
| Redhill Biopharma INC. | $11.49 | 2020 | |
| Stratus Medical, LLC | $10.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snigdha Ancha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.